Medicare Reworks the Payment Plumbing for Kidney Dialysis
Published Date: 7/2/2025
Proposed Rule
Summary
Starting in 2026, Medicare is updating how it pays for kidney dialysis for people with end-stage renal disease and those with acute kidney injury. The rule also tweaks quality programs and changes the ESRD Treatment Choices Model to improve care and payment fairness. Patients, dialysis centers, and healthcare providers should watch for these changes, with public comments open until August 29, 2025.
Analyzed Economic Effects
8 provisions identified: 1 benefits, 3 costs, 4 mixed.
CY 2026 ESRD base rate rises to $281.06
For calendar year (CY) 2026, CMS proposes an ESRD Prospective Payment System (PPS) base rate of $281.06 per treatment, up from $273.82 in CY 2025. CMS estimates aggregate Medicare payments to ESRD facilities would increase by about $160 million in CY 2026 and beneficiary coinsurance payments would increase by about 1.9% (approximately $30 million).
Continuation of TDAPA drug payments in 2026
CMS proposes post‑TDAPA add-on payment amounts for specific drugs in CY 2026: Korsuva at $0.2633 per treatment and DefenCath at $1.4780 per treatment in the quarters specified. CMS estimates combined TDAPA payments for continuing drugs in CY 2026 would be about $480 million, with roughly $100 million attributable to beneficiary coinsurance.
ESRD QIP measure removals and survey reduction
CMS proposes to remove three reporting measures from the ESRD Quality Incentive Program (QIP) beginning with Payment Year (PY) 2027: Facility Commitment to Health Equity, Screening for Social Drivers of Health, and Screen Positive Rate for Social Drivers of Health. Beginning with PY 2028, CMS proposes to update the In‑Center Hemodialysis CAHPS clinical measure and shorten the ICH CAHPS survey by removing 23 questions; CMS estimates the overall economic impact of PY 2027 at approximately $146.8 million and PY 2028 at approximately $143.1 million (including $124.7 million in information collection costs and payment reductions of about $22.1 million for PY 2027 and $18.4 million for PY 2028).
TDAPA eligibility timeframe shortened to 3 years
CMS proposes to change the TDAPA eligibility window so that a new renal dialysis drug or biological product must have been approved by the FDA within the past 3 years at the time of TDAPA application. This eligibility timeframe would apply to TDAPA applications submitted on or after January 1, 2028.
AKI dialysis payment set to $281.06
CMS proposes the annual payment rate for renal dialysis furnished to individuals with acute kidney injury (AKI) for CY 2026 to be $281.06, the same as the proposed ESRD PPS base rate. CMS estimates aggregate Medicare payments for AKI dialysis would increase by $1 million (a 1.8% increase) in CY 2026 compared to CY 2025.
Outlier payment amounts for CY 2026 decrease
CMS proposes updates to the ESRD outlier policy and would reduce the fixed dollar loss (FDL) and Medicare allowable payment (MAP) amounts for CY 2026: pediatric FDL from $234.26 to $148.38 and pediatric MAP from $59.60 to $44.09; adult FDL from $45.41 to $12.74 and adult MAP from $31.02 to $22.07. CMS reports outlier payments represented approximately 0.8% of total Medicare payments in CY 2024 (below the 1.0% target).
New payment adjustment for non‑contiguous areas (NAPA)
CMS proposes a Non-Contiguous Areas Payment Adjustment (NAPA) for ESRD facilities located in Alaska, Hawaii, Guam, American Samoa, and the Northern Mariana Islands to account for certain non-labor costs not captured in the wage index. CMS proposes the NAPA to be budget neutral and would apply a corresponding budget neutrality factor of 0.99859 to the CY 2026 ESRD PPS base rate.
ETC Model termination as of Dec 31, 2025
CMS proposes to terminate the End-Stage Renal Disease Treatment Choices (ETC) Model effective December 31, 2025, and to limit application of the 42 CFR part 512, subpart C payment adjustments to claims with service dates on or after January 1, 2021 and on or before December 31, 2025. CMS estimates the net Federal impact of terminating the ETC Model would be approximately $1 million in savings.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22381, Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage
This new rule updates how Organ Procurement Organizations (OPOs) operate to help get more life-saving organs to people who need transplants. It changes some definitions, competition rules, and appeal processes to make OPOs work better and be held accountable. These changes start January 4, 2027, and aim to save more lives without adding extra costs.
2026-22194, Medicare Program; CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury (AKI) Dialysis Payment, and ESRD Quality Incentive Program
Starting January 1, 2027, Medicare is updating how it pays for kidney dialysis treatments for people with End-Stage Renal Disease (ESRD) and those with Acute Kidney Injury (AKI). These changes include new payment rates and updated quality rules to make sure patients get the best care. If you’re a dialysis provider or patient, expect some shifts in payments and quality standards that aim to improve treatment and support innovation.
2026-21420, Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026
This new Medicare rule will help people with low incomes pay less for their prescriptions, make sure health provider lists are accurate, and hold pharmacy benefit managers more accountable. If you use Medicare Part D or work with pharmacies and providers, these changes could affect you starting soon. Comments on the rule are open until December 15, 2026, so now’s the time to speak up!
2026-20281, Global Benchmark for Efficient Drug Pricing (GLOBE) Model
Starting November 30, 2026, Medicare will use the new GLOBE Model to help lower the cost of certain drugs for people on Original Medicare. This model changes how drug price increases are calculated, aiming to save money for both patients and the Medicare program without cutting care quality. If you’re on Medicare Part B, expect smarter drug pricing that helps keep your healthcare affordable.
2026-20131, Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027 and Updates to the IRF Quality Reporting Program; Correction
This correction fixes some technical mistakes in the Medicare payment rules for inpatient rehab facilities starting October 1, 2026. It mainly affects hospitals and rehab centers by clarifying how wage data and payments are calculated, ensuring fairer payment rates for fiscal year 2027. No big changes in money, but it keeps everything accurate and on track.
2026-19959, Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2027; Correction
This correction fixes some technical mistakes in Medicare payment rules for skilled nursing facilities starting October 1, 2026. It mainly affects how hospital data is used to calculate payments, making sure no current hospitals are wrongly excluded. These tweaks help keep Medicare payments fair and accurate for providers and patients.
Previous / Next Documents
Previous: 2025-12347, Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies
Starting in 2026, Medicare is updating how it pays for home health care and improving quality checks to make sure patients get the best care. Durable medical equipment suppliers will see new rules and bidding updates that could affect costs and services. These changes affect home health agencies, equipment suppliers, and patients, with new payment rates and policies kicking in next year.
Next: 2025-12369, Airworthiness Directives; Bombardier, Inc., Airplanes
The FAA wants all Bombardier BD-100-1A10 airplane owners to check their horizontal stabilizer trim actuators (HSTAs) because some parts that should have been replaced were mistakenly reused. If the parts are affected, they must be swapped out to keep flights safe. Comments on this plan are open until August 18, 2025, so owners should act fast to avoid any costly or risky delays.